title: Treatment decisions for patients with active multiple sclerosis.
authors: Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas2Neurology Section, VA North Texas Health Care System, Medical Service, Dallas3Department of Neurology, Klinikum rechts der Isar, Technische Universität.
authors: Olaf
authors: O
authors: Stüve
authors: Department of Systems Medicine, Multiple Sclerosis Clinical and Research Center, Tor Vergata University and Hospital, Rome, Italy6Istituto Di Ricovero e Cura a Carattere Scientifico, Fondazione Santa Lucia, Centro Europeo di Ricerca sul Cervello, Rome, It.
authors: Diego
authors: D
authors: Centonze
mesh_terms: D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016899:Interferon-beta / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011409:Propylene Glycols / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives*
chemical_list: D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D016899:Interferon-beta; D013110:Sphingosine